RSC Pharmaceutics – Issue 5

We are delighted to share Issue 5 of RSC Pharmaceutics. Read our new open access journal, publishing crucial research on pharmaceutics, which has the potential to drive real change in worldwide health.

“RSC Pharmaceutics will provide a platform for researchers to showcase their best work in this field and contribute to the advancement of Pharmaceutics. I look forward to promoting this journal and its published research to the community.”

Yvonne Perrie, Editor-in-Chief, RSC Pharmaceutics

 

Here are a few of the articles featured in our fifth issue:

 

Graphical abstract: Nano-steps in altered opioid pharmacokinetics: a perspective on potential drug delivery post-bariatric surgery applications

Nano-steps in altered opioid pharmacokinetics: a perspective on potential drug delivery post-bariatric surgery applications

A. E. Avanu, A. M. Ciubotariu, A. M. Ciornei, A. D. Cozmîncă and G. Dodi*

RSC Pharm., 2024,1, 864-878

https://doi.org/10.1039/D4PM00187G

 

 

 

 

 

Graphical abstract: Reconceptualising mucoadhesion for future medicines

Reconceptualising mucoadhesion for future medicines

Michael T. Cook* and David Shorthouse

RSC Pharm., 2024,1, 949-957

https://doi.org/10.1039/D4PM00149D

 

 

 

 

 

Graphical abstract: Increased thermal stability and retained antibacterial properties in a sulbactam and amantadine salt: towards effective antibacterial–antiviral combination therapies

Increased thermal stability and retained antibacterial properties in a sulbactam and amantadine salt: towards effective antibacterial–antiviral combination therapies

Josephine Bicknell, Ivan Bondarenko, Alice Colatrella, Elani J. Cabrera-Vega, Jesus Daniel Loya,  Delbert S. Botes, Jay L. Mellies and Gonzalo Campillo-Alvarado

RSC Pharm., 2024,1, 958-962

https://doi.org/10.1039/D4PM00247D

 

 

 

Graphical abstract: Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection

Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection

Amalendu P. Ranjan, Daniel J. Czyzyk, Griselle Martinez-Traverso, Aygul Sadiqova, Margarita Valhondo, Deborah A. Schaefer, Krasimir A. Spasov, William L. Jorgensen, Jamboor K. Vishwanatha, Michael W. Riggs, Alejandro Castellanos-Gonzalez and Karen S. Anderson

RSC Pharm., 2024,1, 963-975

https://doi.org/10.1039/D4PM00093E

 

 

 

Graphical abstract: Structure–activity relationships of DNA nanocarriers based on the amphipathic cell penetrating peptide transportan 10

Structure–activity relationships of DNA nanocarriers based on the amphipathic cell penetrating peptide transportan 10

Lucas Rodrigues de Mello, Tâmisa Seeko Bandeira Honda, Sang Won Han, Valeria Castelletto, Ian William Hamley, Ly Porosk, Ülo Langelcd and Emerson Rodrigo da Silva

RSC Pharm., 2024,1, 976-993

https://doi.org/10.1039/D4PM00065J

 

 

 

 

These articles and our future publications are free to access by anyone.

Start reading now

RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.